Anonymous
Guest
Anonymous
Guest
I will be opening my best bottle of wine and savoring every word of the WSJ report. Great news like this doesn't come along everyday. I told you lemmings to get out months ago...
I will be opening my best bottle of wine and savoring every word of the WSJ report. Great news like this doesn't come along everyday. I told you lemmings to get out months ago...
We are right where we planned to be. 1 for every 400 scripts is just where we need to be. So eat our assholes.
We are right where we planned to be. 1 for every 400 scripts is just where we need to be. So eat our assholes.
I don't see why you are all being so negative... Remember that Rome wasn't built over-night. With the economy the way it is, this drug will just be a little slower than expected upon climbing to the 2-3 billion dollar a year range. After all, we have much superior efficacy to Plavix and Effient will save many, many lives so it is well worth the premium price... Think about it, what is your life worth to you?
When Plavix was launched (as compared against aspirin) there were no "managed care" or "prior authorization" issues. Be patient, as there is a place in the market for Effient. Don't forget that 30% - 60% of Plavix patients are non-responders.
YES!...be patient Effient sales force. Our drug has a black box WARNING against its use and is more expensive than the gold standard which will be pushed because it is going generic and when it goes generic. So Specialty, how do you feel today?
WOW, maybe this is why our sales are anemic. Listen up office based rep...we DO NOT save lives over plavix nor is there any data to suggest that...that equation was equivalent. Read your materials first before you speak up.I don't see why you are all being so negative... Remember that Rome wasn't built over-night. With the economy the way it is, this drug will just be a little slower than expected upon climbing to the 2-3 billion dollar a year range. After all, we have much superior efficacy to Plavix and Effient will save many, many lives so it is well worth the premium price... Think about it, what is your life worth to you?
WOW, maybe this is why our sales are anemic. Listen up office based rep...we DO NOT save lives over plavix nor is there any data to suggest that...that equation was equivalent. Read your materials first before you speak up.
can someome please inform me of Effient's 1st qtr projections. serious responders only.
500 Million. This will be our quarter! We intended the full 3rd quarter to be the difference maker in the life of this product. We have since day one. P&T have now had time to add it on, the availability is there for the IC's. Interest has been shown and the IC's are seeing the results. It will happen!!